 Prof. DV Phuoc (HCMC), Prof. H.-F. Vöhringer (Berlin) VIETNAMESE GERMAN CONGRESS HOI NGHI DUC VIET NEW CHALLENGES IN CARDIOVASCULAR TECHNIQUES THÁCH THỨC MỚI VỀ KỸ THUẬT TIM MẠCH Venue/Địa điểm: Rex Hotel 141 Nguyen Hue St., Dist. 1, Ho Chi Minh City, Viet Nam Time/Thời gian: Sunday, 30th November 2014 8:30 – 15:15 Chairpersons: Prof. Dr. Dang Van Phuoc Prof. Dr. Volker Klauss PD Dr. Wolfgang Fehske Prof. Dr. Pham Nguyen Vinh Prof. Dr. Georg Dieter Kneissl Prof. Dr. Truong Quang Binh Organization:
in cooperation with:
Program/Chương trình: 08:30-08:40 GREETING CHÀO MỪNG HỘI NGHỊ Prof. Dr. Dang Van Phuoc Prof. Dr. Nguyen Si Huyen Prof. Dr. Pham Nguyen Vinh Session I: Clinical Cardiology Chairpersons: Prof. Volker Klauss/Prof. Dang Van Phuoc 08:40-09:00 Sport and arrhythmia Thể thao và Rối loạn nhịp Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany 09:00-09:20 Catheter ablation of atrial fibrillation: newest developments Đốt điện sinh lý trong rung nhĩ: Những tiến bộ mới Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 09:20-09:40 Updated new guidelines in the treatment of hypertension Cập nhật khuyến cáo mới trong điều trị Tăng huyết áp Prof. Dang Van Phuoc, The president of Ho Chi Minh Cardiovascular Association, Viet Nam 09:40-10:00 Catheter ablation of ventricular tachyarrhythmias: epicardiac approach: when? how? Đốt điện sinh lý trong nhanh thất: Tiếp cận từ màng ngoài tim: Khi nào? Như thế nào? Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 10:00-10:20 3-D-Echocardiography Siêu âm tim 3-D PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany TEA BREAK Session II: Clinical Cardiology & Echocardiography & Cardiac surgery Chairpersons: Prof. Dr. Georg-D. Kneissl/Prof. Pham Nguyen Vinh 10:35-10:55 Fixed dose combination therapy in the treatment of hypertension Phối hợp thuốc liều cố định trong điều trị Tăng huyết áp Prof. Truong Quang Binh, Vice-director of Ho Chi Minh Medical University, Viet Nam 10:55-11:15 Sleep-related breathing disorders and heart failure Rối loạn nhịp thở khi ngủ và suy tim Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany 11:15-11:35 Clinically important drug interactions in cardiovascular therapy Những tương tác thuốc quan trọng trên lâm sàng trong điều trị bệnh tim mạch Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany 11:35-11:55 Current clinical practice in Europe for management of atrial fibrillation Thực hành lâm sàng trong điều trị rung nhĩ hiện nay tại Châu Âu Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany LUNCH BREAK Session III: Clinical Cardiology & Electrophysiology Chairpersons: PD Dr. Wolfgang Fehske/Prof. Truong Quang Binh 13:00-13:20 The “fibrotic atrial cardiomyopathie (FACM)” : new substrate for atrial fibrillation? Consequences for clinical practice? Bệnh cơ tim xơ hóa tâm nhĩ (FACM)”: Chất nền mới trong rung nhĩ ? Tầm quan trọng trong thực hành lâm sàng ? Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 13:20-13:40 Stress echocardiography Siêu âm tim gắng sức PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany 13:40-14:00 Diabetes and DPP4 Đái tháo đường và DPP4 Prof. Pham Nguyen Vinh, Vice-president of Viet Nam Cardiovascular Association, Viet Nam 14:00-14:20 The net clinical benefit of dabigatran in stroke prevention: What have we learned from recent data? Lợi ích lâm sàng của dabigatran trong phòng ngừa đột quỵ: chúng ta học được gì từ các dữ liệu gần đây? Dr. Ho Huynh Quang Tri, HCM Heart Institude, Viet Nam 14:20-14:40 The aortic valve replacement through the skin Thay van động mạch chủ qua da Dr. Nguyen Huynh Khuong, Tam Duc Hospital, Viet Nam 14:40-15:00 Beyond angiography: modalities for assessment of coronary artery lesions Phương thức đánh giá tổn thương ĐM vành ngoài chụp mạch máu cản quang Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany 15:20-15:30 Closing Remarks Faculty: PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Georg-Dieter Kneissl, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Johannes Gutenberg Universitätsmedizin Mainz, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Prof. Dang Van Phuoc, The president of Ho Chi Minh Cardiovascular Association, Viet Nam Prof. Pham Nguyen Vinh, Vice-president of Viet Nam Cardiovascular Association, Viet Nam Prof. Truong Quang Binh, Vice-director of Ho Chi Minh Medical University, Viet Nam Dr. Ho Huynh Quang Tri, HCM Heart Institude, Viet Nam Dr. Nguyen Huynh Khuong, Tam Duc Hospital, Viet Nam  Prof. PN Vinh (HCMC), Prof. G.D. Kneissl (Mainz)   Empfang von der HCMC Cardiovascular Association: v.l. PD Dr. W. Fehske (Köln), Dr. DQ Nguyen (Köln), Prof. DV Phuoc, President HCMC Cardiovascular Association, Prof. PN Vinh, Vice President.
0 Comments
 4. Vietnamese German Scientific Symposium Nha Trang, 26.11.2014 Venue: Khanh Hoa Hospital Time: 13:30 – 17:00 Organization: Vietnam Heart Association Khanh Hoa Community Hospital Khanh Hoa In Cooperation with
Lectures: Sport and arrhythmia Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Sleep apnea and heart failure Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany Diagnosis and treatment of pulmonary embolism: Role of echocardiography Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany Clinically important drug interactions in cardiovascular therapy Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Current clinical practice in Europe for management of atrial fibrillation Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Beyond angiography: modalities for assessment of coronary artery lesions Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Faculty: Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Prof. Dr. Volker Klauss, Cardiology Munich City Centre, Munich, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany     Vietnamese German Scientific Symposium Hanoi 22.11.2014 Venue: Vietnam National Heart Institute, Bach Mai University Hospital Time: 9:00 – 13:00 Organization: Vietnam National Heart Institute, Bach Mai University Hospital, Hanoi in cooperation with
Lectures: Sport and arrhythmia Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Physical activity is an important factor to reduce cardiovascular risk. 2,5 – 5 hours a week of at least moderate intensity are recommended for adults of all ages in the guidelines for prevention of cardiovascular disease. But physical stress can also harm. There are about 0.2 – 3.0 cases of sudden cardiac death (SCD) in 100 000 young athletes (< 35 years) per year, 90 % of the share related to male athletes. Triathlon, american football and soccer have the most frequent number of arrhythmogenic deaths, highly recognized in the general public. The most important cause of SCD in athletes in a study of Maron (JAMA 2006) is hypertrophic cardiomyopathy (HCM) (36%), another 8 % had undetermined LV hypertrophy, possible HCM. Other and relying heart diseases were coronary artery anomalies (17%), myocarditis (6 %), ARVCM (4 %), channelopathies and other rare heart diseases. Only 3 % of the examined hearts of the athletes with SCD were normal. By screening programs the number of SCD in athletes can be reduced to less than the number in non-athletes (< 35 years) (about 1 / 100000 per year). The medical history has to include exertional problems, syncopes or near-syncopes, and a family history of sudden cardiac deaths under the age of 50 years in close relatives. Among other things cardiomyopathies, arrhythmogenic problems or congenital conditions should be inquired. Physical examinations of the athletes include heart murmurs, femoral pulses, stigmata for a marfan syndrome and brachial artery blood pressure. Associations as the FIFA recommend a precompetition medical assessment including a past and present medical history (e.g. infections), a physical and an orthopedic examination, an 12 lead resting ECG, an echocardiography and laboratory testing before eat testing the eligibility for competitive football. The challenge is to differentiate between the physiological changes of an athletes heart and the pathological features of a underlying heart disease. There is a high prevalence of ECG patterns (e.g. T- wave inversions, early repolarisation patterns) in athletes that have to be evaluated. There is also the need to advise athletes with different arrhythmias concerning participation in competitive sports. And there is a group of patients with acquired or congenital heart diseases that needs recommendations for participation in competitive or leisure sport activity. Catheter ablation of atrial fibrillation: newest developments Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Atrial fibrillation (AF) is the most common arrhythmia and has gained increasingly more attention due to new treatment options, particularly catheter ablation. Growing experience with this technique and better AF suppression compared with antiarrhythmic medication have paved the way for its extended use and indication. At this point, it is recommended for symptomatic patients if antiarrhythmic drugs failed and in selected young symptomatic patients as first line therapy. We present an actualized overview of the different ablation techniques and the newest developments. The “fibrotic atrial cardiomyopathie (FACM)” : new substrate for atrial fibrillation? Consequences for clinical practice? Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany The atrial structure/substrate of patients with atrial fibrillation and clinically similar characteristics can present very differently, and also the 'phenotype' (i.e. paroxysmal, persistent, and long standing persistent) of the arrhythmia cannot comprehensively explain these differences. It was unclear why some patients stay in paroxysmal AF for decades, whereas other patients with the same characteristics progress to persistent AF within a few months. In this review, evidence is described that AF patients without apparent structural heart disease have a chronic fibrotic bi-atrial substrate. There is also evidence from intraoperatively obtained specimen analysis, post-mortem autopsy findings, electroanatomic mapping studies, and delayed enhancement-MRI investigations that a higher mean value of fibrosis is detected in patients with persistent vs. paroxysmal AF but that the variability in the extend of fibrosis is always very high with part of paroxysmal AF patients having massive fibrosis and part of persistent AF patients showing mild fibrosis. Catheter ablation of ventricular tachyarrhythmias: epicardiac approach: when? how? Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Electrical storm (ES) is one of the most challenging clinical scenarios facing electrophysiologists, and in certain settings emergency ablation should be performed. The majority of ES occurs in patients with structural heart disease, predominantly coronary heart disease and nonischemic heart disease like right ventricular arrhythmogenic dysplasia and previous myocarditis as well as other cardiomyopathies. Implantable cardioverter-defibrillators (ICDs) are the first-line therapy in patients with ventricular tachycardia (VT) and structural heart disease. Recurrent VT episodes or ES are major problems in patients who receive an ICD after a spontaneous sustained VT. Catheter ablation has a high success rate in the acute setting in eliminating clinical VT. However, several factors make enodocardial catheter ablation of VT more difficult especially in advanced ischemic heart disease with heart failure and aneurysm. Frequently in nonischemic cardiomyopathies (NICM) there tends to be an epicardial and intramyocardial substrate where the critical VT zone can occasionally be epicardial or intramural in location. In some patients, an epicardial approach should be warranted first together with an endocardial approach or after failure of enodocardial ablation. 3-D-Echocardiography PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Stressechocardiography PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Sleep apnea and heart failure Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at Pham Ngoc Thach University of Medicine HCMC, HELIOS St. Marienberg Hospital Helmstedt, Academic Hospital of the University Magdeburg, Germany The prevalence of sleep-related breathing disorders both obstructive sleep apnea and central sleep apnea in the form of Cheyne-Stokes respiration in heart failure is generally high. With increasing heart failure, an increase in central sleep apnea is to be expected. While obstructive sleep apnea is regarded as an independent cardiovascular risk factor, the central sleep apnea with Cheyne-Stokes respiration, seems to be rather a symptom of heart failure, which reflects the degree of heart failure. Pathophysiologically the activation of the sympathetic nervous system and the repetitive oxygen desaturations contribute most to adversely affecting the cardiac function. The Continuous Positive Airway Pressure therapy (CPAP) is the treatment of choice for obstructive sleep apnea. Concerning the treatment of central sleep apnea and Cheyne-Stokes respiration, the adaptive servo ventilation (ASV) is currently recommended. Sự phổ biến của rối loạn hô hấp liên quan đến giấc ngủ dưới dạng ngưng thở tắc nghẽn cũng như ngưng thở trung tâm khi ngủ đặc biệt là trong dạng thở Cheyne-Stokes ở bệnh nhân suy tim nói chung là cao. Sự gia tăng suy tim thì thông thường cùng đi kèm với sự gia tăng ngưng thở trung tâm khi ngủ. Trong khi ngưng thở tắc nghẽn khi ngủ được coi là một yếu tố nguy cơ tim mạch độc lập, thì ngưng thở trung tâm khi ngủ với dạng thở Cheyne-Stokes là một biểu hiện của triệu chứng suy tim, phản ánh mức độ suy tim. Sinh lý bệnh học cơ bản là sự kích hoạt hệ thống thần kinh giao cảm và giảm oxy lặp đi lặp lại gây ảnh hưởng xấu đến chức năng tim. Liệu pháp thở áp suất dương liên tục (CPAP) là điều trị lựa chọn cho ngưng thở tắc nghẽn khi ngủ. Liệu pháp điều trị hiện nay được khuyến cáo cho điều trị ngưng thở trung tâm khi ngủ và thở dạng Cheyne-Stokes là dạng thở máy đáp ứng thông khí tự động (adaptive servo ventilation). Clinically important drug interactions in cardiovascular therapy Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Current clinical practice in Europe for management of atrial fibrillation Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany Atrial fibrillation (AF), the most common irregular heart rhythm, is a major factor for thromboembolic stroke and its prevalence is growing worldwide. The risk of ischemic stroke or thromboembolism is 4 to 5 times higher in patients with AF, with similar risks seen both in patients with paroxysmal as well as permanent AF. Approximately every fifth stroke is caused by thromboembolism secondary to AF and strokes related to AF tend to lead to more severe disability than strokes of other etiologies. The presence of AF is independently associated with a doubling of mortality rates (Lip, 2014). Based upon these statistic numbers the management of AF is of utmost importance. In the session data are presented from a series of surveys conducted to enhance the understanding of clinical practice patterns in the treatment of AF in the member countries of the European Society of Cardiology (ESC). Faculty: PD Dr. Wolfgang Fehske, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Dr. Birgit Gerecke, MVZ Ambulatory Cardiac Centre Peine, Germany Prof. Dr. Si Huyen Nguyen, Vietnamese German Faculty of Medicine at the Pham Ngoc Thach University of Medicine /HCM City, Academic Hospital HELIOS St. Marienberg Helmstedt, Germany Dr. Dinh Quang Nguyen, Medical Clinic III, Department of Cardiology, St. Vinzenz-Hospital, Köln, Germany Prof. Dr. Hans-F. Voehringer, DRK Clinics Berlin, Germany  Ehrenplakette für Professor Dr. med. Rolf Engberding und Dr. med. Si Huyen Nguyen Braunschweig. Am 12. November 2014 wurde Professor Dr. med. Rolf Engberding aus Wolfsburg und Dr. med. Si Huyen Nguyen aus Helmstedt die Ehrenplakette der Ärztekammer Niedersachsen (ÄKN) von dem Vorsitzenden der ÄKN-Bezirksstelle Braunschweig, Dr. med. Hubert Binkhoff, überreicht. Die Ehrenplakette der ÄKN wird solchen Ärzten überreicht, die sich über die alltägliche ärztliche Tätigkeit hinaus in besonderem Maße für die niedersächsische Ärzteschaft verdient gemacht haben. Dr. Nguyen und Professor Engberding sind geeignete Adressaten für die Verleihung der Ehrenplakette - sie haben sich über viele Jahre ehrenamtlich in hervorragender Weise für den Ruf und das Ansehen der deutschen Medizin eingesetzt und sich verdient gemacht. Beide Mediziner haben sich seit 1997 maßgeblich in der kontinuierlichen Ausbildung junger vietnamesischer Ärzte sowohl im Rahmen jährlich stattfindender Ausbildungstätigkeiten in städtischen und ländlichen Gebieten Vietnams als auch in der Ausbildung in deutschen Herzkatheterlaboren verdient gemacht. Ein weiterer Schwerpunkt war die Gründung der Akademie zur Förderung der wissenschaftlichen Zusammenarbeit vietnamesischer und deutscher Kardiologen und Herzchirurgen. Ferner sind Dr. Nguyen und Professor Engberding Gründungsmitglieder des 1997 gegründeten Deutsch-Vietnamesischen Förderkreises für Kardiologie e.V. (DVFK). Der DVFK ist ein gemeinnütziger Verein. Zweck des Förderkreises ist die Förderung von Gesundheitsprojekten zur Erforschung, Verhütung und Bekämpfung kardiovaskulärer Erkrankungen in Zusammenarbeit mit vietnamesischen Ärzten. Erklärtes Ziel dieser Zusammenarbeit ist es, die Völkerverständigung und Freundschaft unter den deutschen und vietnamesischen Ärzten zu fördern und zu festigen. Der Satzungszweck wird insbesondere durch die Durchführung wissenschaftlicher Veranstaltungen, Vergabe von Stipendien zur Förderung junger medizinischer Wissenschaftler, Förderung und Pflege der Zusammenarbeit im Sinne der Völkerverständigung und Freundschaft zwischen deutschen und vietnamesischen Medizinern verwirklicht. Niedersächsisches Ärzteblatt 01/2015 http://www.haeverlag.de/nae/n_beitrag.php?id=4692 Zur weiteren Information: https://www.wolfsburger-nachrichten.de/wolfsburg/doerfer/article151661995/Ehrenplakette-fuer-verdiente-Aerzte.html |
Archiv
November 2019
|
RSS Feed
